Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...
All content for The Science of Talent by BioTalent Canada is the property of BioTalent Canada and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...
Growing the Digital Ag Eco-System AND Leaving No One Behind
The Science of Talent by BioTalent Canada
28 minutes
3 years ago
Growing the Digital Ag Eco-System AND Leaving No One Behind
Episode two of The Science of Talent focuses on the Agri-Bio subsector with Jacqueline Keena of EMILI. The Enterprise Machine Intelligence and Learning Initiative is dedicated to accelerating the adoption of the digital agriculture eco system in Manitoba and across the prairies. It was created to prepare and empower the Manitoba economy to leverage digital disruption. EMILI was founded on two strategic pillars: To provide information and support to industry as it considers...
The Science of Talent by BioTalent Canada
Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that. Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model i...